高胆固醇血症通过意识子的四水生物胺依赖机制取消了晚期预条件
Xian-Liang Tang1, Hitoshi Takano, Yu-Ting Xuan
1Institute of Molecular Cardiology, University of Louisville, The Jewish Hospital Heart and Lung Institute, Louisville, KY, USA.
Circulation
|September 28, 2005
概括
高胆固醇血清症通过抑制四二素 (BH4) 上调来阻断晚期缺血预条件 (PC) 的心脏保护作用. 这种机制对于在没有高胆固醇的情况下维持心脏保护至关重要.
科学领域:
- 心血管生理学心血管生理学
- 分子心脏病学分子心脏病学
- 缺血性心脏病是一种心脏病.
背景情况:
- 晚期缺血预调 (PC) 在健康模型中提供心脏保护.
- 高胆固醇血症对晚期PC的影响尚不清楚.
- 四基生物素 (BH4) 是心血管功能中的关键辅因子.
研究的目的:
- 调查高胆固醇血症是否会影响晚期PC的心脏病缓解效果.
- 确定BH4依赖性途径是否调解高胆固醇血症中晚期PC的丧失.
主要方法:
- 具有正常或高胆固醇饮食的有意识的子接受了缺血性PC.
- 冠状动脉封闭和再注血协议被用于诱导心肌梗塞.
- 评估了BH4水平和BH4合成抑制剂 (N-乙血) 的作用.
主要成果:
- 在正常胆固醇贫血的子中,PC降低了心脏病发作的大小,增加了心肌BH4.
- 在高胆固醇贫血的子中,PC未能减少心脏病发作的大小或增加BH4.
- 抑制BH4合成消除了PC在正常胆固醇贫血子中的保护作用.
结论:
- 高胆固醇血症取消了晚期PC的抗心脏病效应,并削弱了BH4上调.
- 抑制BH4合成模仿高胆固醇血症对晚期PC的影响.
- 高胆固醇血症通过阻止BH4上调节来损害晚期PC,这对于可诱导的氧化合成酶至关重要.
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...


